Eric Tran

11.6k total citations · 6 hit papers
54 papers, 7.3k citations indexed

About

Eric Tran is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Eric Tran has authored 54 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 43 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Eric Tran's work include Immunotherapy and Immune Responses (35 papers), CAR-T cell therapy research (34 papers) and Cancer Immunotherapy and Biomarkers (27 papers). Eric Tran is often cited by papers focused on Immunotherapy and Immune Responses (35 papers), CAR-T cell therapy research (34 papers) and Cancer Immunotherapy and Biomarkers (27 papers). Eric Tran collaborates with scholars based in United States, Canada and Malaysia. Eric Tran's co-authors include Steven A. Rosenberg, Paul F. Robbins, Alena Gros, John R. Wunderlich, Yong‐Chen Lu, Jared J. Gartner, Simon Turcotte, Maria R. Parkhurst, Anna Pasetto and Todd D. Prickett and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Eric Tran

53 papers receiving 7.1k citations

Hit Papers

Cancer Immunotherapy Based on Mutation-Specific CD4+ T Ce... 2014 2026 2018 2022 2014 2016 2014 2016 2015 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
    2014 1.3k citations Eric Tran, Simon Turcotte et al. profile →
  2. T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
    2016 950 citations Eric Tran, Paul F. Robbins et al. profile →
  3. PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
    2014 772 citations Alena Gros, Paul F. Robbins et al. Journal of Clinical Investigation profile →
  4. Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
    2016 597 citations Alena Gros, Maria R. Parkhurst et al. profile →
  5. Immunogenicity of somatic mutations in human gastrointestinal cancers
    2015 557 citations Eric Tran, Yong‐Chen Lu et al. profile →
  6. Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer
    2022 319 citations Rom S. Leidner, Steven A. Rosenberg et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Tran United States 30 6.0k 4.9k 1.7k 690 556 54 7.3k
Jared J. Gartner United States 30 5.2k 0.9× 4.3k 0.9× 2.3k 1.4× 733 1.1× 628 1.1× 60 6.9k
Alena Gros Spain 28 4.3k 0.7× 3.6k 0.7× 1.5k 0.9× 939 1.4× 378 0.7× 54 5.6k
Yong F. Li United States 27 4.7k 0.8× 4.3k 0.9× 1.4k 0.8× 835 1.2× 419 0.8× 43 5.9k
Daniel J. Powell United States 49 6.8k 1.1× 5.3k 1.1× 2.0k 1.2× 1.5k 2.2× 417 0.8× 118 8.8k
Linda Rogers-Freezer United States 9 4.9k 0.8× 4.4k 0.9× 1.6k 1.0× 1.4k 2.1× 257 0.5× 10 6.4k
Mona El‐Gamil United States 29 4.0k 0.7× 4.4k 0.9× 2.8k 1.6× 938 1.4× 481 0.9× 41 6.6k
Shin Foong Ngiow United States 31 4.8k 0.8× 4.4k 0.9× 1.3k 0.7× 151 0.2× 284 0.5× 44 7.1k
Anna Pasetto United States 21 3.3k 0.6× 2.7k 0.6× 957 0.6× 397 0.6× 357 0.6× 43 4.0k
Joshua Brody United States 35 2.8k 0.5× 3.0k 0.6× 1.1k 0.6× 273 0.4× 405 0.7× 147 4.9k
Thomas E. Darga United States 25 3.1k 0.5× 2.5k 0.5× 1.6k 1.0× 210 0.3× 491 0.9× 34 5.4k

Countries citing papers authored by Eric Tran

Since Specialization
Citations

This map shows the geographic impact of Eric Tran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Tran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Tran more than expected).

Fields of papers citing papers by Eric Tran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Tran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Tran. The network helps show where Eric Tran may publish in the future.

Co-authorship network of co-authors of Eric Tran

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Tran. A scholar is included among the top collaborators of Eric Tran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Tran. Eric Tran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tran, Eric. (2024). More T cell receptors to the RAScue in cancer?. Journal of Clinical Investigation. 134(21). 1 indexed citations
2.
3.
Minegishi, Yuriko, Noriko Iwamoto, Takashi Shimada, et al.. (2023). 149 Simultaneous identification of KRAS mutation-carrying multiple neoepitopes by differential ion mobility-assisted targeted-mass spectrometry. SHILAP Revista de lepidopterología. A169–A169. 1 indexed citations
4.
Iwamoto, Noriko, Yoshinobu Koguchi, Akinobu Hamada, et al.. (2022). A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics. The Analyst. 147(19). 4275–4284. 4 indexed citations
5.
Perotin, Jeanne‐Marie, Fabien Gierski, L. Bolko, et al.. (2022). Cluster analysis unveils a severe persistent respiratory impairment phenotype 3-months after severe COVID-19. Respiratory Research. 23(1). 199–199. 2 indexed citations
6.
Duhen, Rebekka, Alexandra K. Frye, Venkatesh Rajamanickam, et al.. (2022). PD-1 and ICOS coexpression identifies tumor-reactive CD4+ T cells in human solid tumors. Journal of Clinical Investigation. 132(12). 45 indexed citations
7.
Rajamanickam, Venkatesh, Carmen Ballesteros‐Merino, David Ross, et al.. (2021). Robust Antitumor Immunity in a Patient with Metastatic Colorectal Cancer Treated with Cytotoxic Regimens. Cancer Immunology Research. 9(6). 602–611. 7 indexed citations
8.
Duhen, Rebekka, Carmen Ballesteros‐Merino, Alexandra K. Frye, et al.. (2021). Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells. Nature Communications. 12(1). 1047–1047. 114 indexed citations
9.
Li, Yongzheng, Pengcheng Wei, Hexiang Deng, et al.. (2021). Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy. OncoImmunology. 10(1). 1868130–1868130. 17 indexed citations
10.
Hamilton, Sarah, Nicole G. Chau, Eric Berthelet, et al.. (2021). Patient-reported outcomes and complications during head and neck cancer radiotherapy before versus during the COVID-19 pandemic. Supportive Care in Cancer. 30(3). 2745–2753. 2 indexed citations
11.
12.
Lu, Yong‐Chen, Lee Jia, Zhili Zheng, et al.. (2019). Single-Cell Transcriptome Analysis Reveals Gene Signatures Associated with T-cell Persistence Following Adoptive Cell Therapy. Cancer Immunology Research. 7(11). 1824–1836. 36 indexed citations
13.
Lo, Winifred, Maria R. Parkhurst, Paul F. Robbins, et al.. (2019). Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer. Cancer Immunology Research. 7(4). 534–543. 105 indexed citations
14.
Malekzadeh, Parisa, Anna Pasetto, Paul F. Robbins, et al.. (2019). Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers. Journal of Clinical Investigation. 129(3). 1109–1114. 197 indexed citations
15.
Draper, Lindsey M., Mei Li M. Kwong, Alena Gros, et al.. (2015). Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6. Clinical Cancer Research. 21(19). 4431–4439. 141 indexed citations
16.
Turcotte, Simon, Alena Gros, Eric Tran, et al.. (2013). Tumor-Reactive CD8+ T Cells in Metastatic Gastrointestinal Cancer Refractory to Chemotherapy. Clinical Cancer Research. 20(2). 331–343. 45 indexed citations
17.
Chinnasamy, Dhanalakshmi, Eric Tran, Zhiya Yu, et al.. (2013). Simultaneous Targeting of Tumor Antigens and the Tumor Vasculature Using T Lymphocyte Transfer Synergize to Induce Regression of Established Tumors in Mice. Cancer Research. 73(11). 3371–3380. 90 indexed citations
18.
Tran, Eric, Dhanalakshmi Chinnasamy, Zhiya Yu, et al.. (2013). Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia. The Journal of Experimental Medicine. 210(6). 1125–1135. 349 indexed citations
19.
Nielsen, Julie S., Darin A. Wick, Eric Tran, Brad H. Nelson, & John R. Webb. (2010). An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies. Journal of Immunological Methods. 360(1-2). 149–156. 13 indexed citations
20.
Tran, Eric, et al.. (2007). STAT5 Is Essential for Akt/p70S6 Kinase Activity during IL-2-Induced Lymphocyte Proliferation. The Journal of Immunology. 179(8). 5301–5308. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jared J. Gartner Breakdown of academic impact, for papers by Alena Gros Breakdown of academic impact, for papers by Yong F. Li Breakdown of academic impact, for papers by Daniel J. Powell Breakdown of academic impact, for papers by Linda Rogers-Freezer Breakdown of academic impact, for papers by Mona El‐Gamil Breakdown of academic impact, for papers by Shin Foong Ngiow Breakdown of academic impact, for papers by Anna Pasetto Breakdown of academic impact, for papers by Joshua Brody Breakdown of academic impact, for papers by Thomas E. Darga
Rankless by CCL
2026